Brenden is a Director, Global Health Economics at Magnolia Market Access. He has over a decade of experience in pharmaceutical and healthcare consulting, with a primary focus on health economic modeling.
Brenden has extensive experience in the conceptualization, design, and development of advanced health economic models and methodologies. His proficiency includes cost-effectiveness analysis, budget impact assessments, cost-minimization analysis, and creation of cost calculators. With a specialization in Excel and VBA, he is adept at employing techniques such as Markov models, Monte Carlo simulations, scenario analyses, and sensitivity analyses, complemented by the development of VBA-based user interfaces.
Brenden is dedicated to applying data-driven strategies to address complex challenges facing pharmaceutical and healthcare stakeholders. He is particularly skilled in creating intuitive and visually compelling designs that enhance user experience while preserving the integrity and robustness of the underlying framework. His experience also extends to automation, epidemiology forecasting, chart reviews, and data management.
Prior to joining Magnolia, Brenden worked at a consultancy developing robust health economic models and fit-for-purpose technical solutions in the HEOR sector for pharmaceutical clients. His work involved leveraging data from systematic or targeted literature reviews, clinical trials, chart reviews, and RWE analyses to support products throughout their lifecycle.